MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal Adenocarcinoma
Clinical trial NCT02551055 · TERMINATED
Trial details
- NCT number
- NCT02551055
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-15
- Primary completion
- 2017-02-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.